The occurrence of auditory dysfunction in children with TB receiving ototoxic medication at a TB hospital in South Africa

Int J Pediatr Otorhinolaryngol. 2015 Jul;79(7):1101-5. doi: 10.1016/j.ijporl.2015.04.040. Epub 2015 May 6.

Abstract

Objectives: to describe the auditory dysfunction of children with tuberculosis receiving ototoxic medication at a residential TB hospital in the Cape Town metropolitan area.

Methods: A descriptive survey research design was adopted. The auditory status of participants was evaluated by otoscopy, immittance, audiometry or OAE and AABR (depending on the age).

Study sample: 29 in-patients (7 months to 16.6 years).

Results: Fifty five percent of participants presented with middle ear abnormalities (n=16) and 48% (n=12) had sensorineural or mixed hearing loss. The degree of hearing loss ranged from mild to profound in 16% of the ears. The conventional pure-tone average of .5, 1, & 2 kHz did not allow for the determination of the degree of hearing loss in the remaining 18% which had high frequency hearing loss.

Conclusions: The high occurrence of hearing loss necessitates the implementation of monitoring program for children receiving ototoxic medication. Consideration should be given to using the average of hearing thresholds at 4, 6 and 8 kHz to determine the classification of degree of hearing loss in cases of ototoxicity.

Keywords: Children; Hearing loss; Monitoring; Ototoxicity; TB.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Antitubercular Agents / adverse effects*
  • Antitubercular Agents / therapeutic use
  • Child
  • Child, Preschool
  • Female
  • Hearing Loss, Conductive / diagnosis
  • Hearing Loss, Conductive / etiology
  • Hearing Loss, Mixed Conductive-Sensorineural / diagnosis
  • Hearing Loss, Mixed Conductive-Sensorineural / etiology
  • Hearing Loss, Sensorineural / chemically induced*
  • Hearing Loss, Sensorineural / diagnosis
  • Hospitalization
  • Humans
  • Infant
  • Male
  • Prospective Studies
  • South Africa
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents